Product Details for NDA 010775
TRILAFON (PERPHENAZINE)
2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PERPHENAZINE
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
TRILAFON (PERPHENAZINE)
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PERPHENAZINE
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
TRILAFON (PERPHENAZINE)
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PERPHENAZINE
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
TRILAFON (PERPHENAZINE)
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: PERPHENAZINE
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: TRILAFON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N010775
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SCHERING CORP SUB SCHERING PLOUGH CORP
Marketing Status: Discontinued
Patent and Exclusivity Information